• 6132 Citations
  • 41 h-Index
1978 …2019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where J. Szebeni is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 18 Similar Profiles
Complement Activation Medicine & Life Sciences
Liposomes Medicine & Life Sciences
Chemical activation Chemical Compounds
Hypersensitivity Medicine & Life Sciences
Swine Medicine & Life Sciences
Nanomedicine Medicine & Life Sciences
Medical nanotechnology Chemical Compounds
Hemoglobins Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1978 2019

Acute physiological changes caused by complement activators and amphotericin b-containing liposomes in mice

Őrfi, E., Mészáros, T., Hennies, M., Fülöp, T., Dézsi, L., Nardocci, A., Rosivall, L., Hamar, P., Neun, B. W., Dobrovolskaia, M. A., Szebeni, J. & Szénási, G., jan. 1 2019, In : International journal of nanomedicine. 14, p. 1563-1573 11 p.

Research output: Article

Open Access
Liposomes
Amphotericin B
Chemical activation
Cholesterol
Phospholipids

Doxebo (doxorubicin-free Doxil-like liposomes) is safe to use as a pre-treatment to prevent infusion reactions to PEGylated nanodrugs

Bavli, Y., Winkler, I., Chen, B. M., Roffler, S., Cohen, R., Szebeni, J. & Barenholz, Y., júl. 28 2019, In : Journal of Controlled Release. 306, p. 138-148 11 p.

Research output: Article

Liposomes
Doxorubicin
Therapeutics
liposomal doxorubicin
Hypersensitivity

PEGylated liposomes: immunological responses

Mohamed, M., Abu Lila, A. S., Shimizu, T., Alaaeldin, E., Hussein, A., Sarhan, H. A., Szebeni, J. & Ishida, T., dec. 31 2019, In : Science and Technology of Advanced Materials. 20, 1, p. 710-724 15 p.

Research output: Review article

Open Access
Liposomes
Polyethylene glycols
Chemical activation
Blood
Immune system